In the context of IBD, TP53 monoclonal mutations observed in high-grade dysplasia of patients with ulcerative colitis were suggested to facilitate escape from oxidative-stress-induced senescence [34]. This evidence concerns the gene TP53 and inflammatory bowel disease.